Archive 2011

PSI appoints Risk Review Group

December 01, 2011

The PSI has appointed a Risk Review Group to advise on the issues around the recently reported error in patient underdosing with the seasonal influenza vaccine in some pharmacies. The Group will look at what the learnings might be from this issue.


The Review Group will comprise:

  • Professor Peter Weedle, adjunct Professor of Pharmacy Practice at the School of Pharmacy in University College Cork, community pharmacist, former member of the PSI Council (Chair)
  • Ms Mary Culliton, former Director of Advocacy with the Quality and Patient Safety Directorate of the HSE. Ms Culliton formerly established a Quality, Risk and Patient Safety Directorate when Director of Corporate Fitness in the former Midland Health Board, prior to the establishment of the HSE. Ms Culliton is also a former Head of Consumer Affairs within the HSE
  • Mr Stephen McMahon, Irish Patients Association, who is an experienced patient advocate and representative.
  • Mr Raymond Anderson, former President of the Council of the Pharmaceutical Society of Northern Ireland and current President of the Commonwealth Pharmacists Association, who is an experienced clinical pharmacy practitioner
  • Ms Marie McConn, experienced community pharmacist practitioner, who is a former member of the PSI Council, and has also held positions with the Irish Pharmacy Union and is a former member of the Irish Medicines Board
  • Mr Tom McGuinn, former Chief Pharmacist of the Department of Health, former member of Irish Medicines Board and GMS Payments Board, who has significant expertise in pharmacy nationally and internationally
  • Dr Brenda Corcoran who is a Consultant in Public Health Medicine in the HSE National Immunisation Office and a member of the National Immunisation Advisory Committee
  • Dr Kevin Connolly, member of the National Immunisation Advisory Committee, who is also a member of the Irish Medicines Board’s Advisory Committee on Human Medicines and is the Irish representative on the European Medicines Agency Paediatric Committee


Back to News List